This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Histone methyltransferase
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | <StructureSection load='1o9s' size='350' side='right' caption='Human histone-lysine N-methyltrasferase Smyd2 complex with S-adenosyl methionine (PDB entry [[2pm4]])' scene=''> | |
| + | |||
== Function == | == Function == | ||
'''Histone methyltransferase''' (HMT) are '''histone-lysine N-methyltransferase''' (KHMT) and '''histone-arginine N-methyltransferase''' (RHMT) which catalyzes the transfer of methyl groups to lysine and arginine residues of histones<ref>PMID:15248813</ref>. HMT use S-adenosyl methionine (SAM) or S-adenosyl homocysteine (SAH) as the methyl donor. KHMT can be SET domain-containing or non-SET domain-containing. The SET domain contains the catalytic core of KHMT and targets the lysine tail region of KHMT. CxxC domain is a zinc finger domain. | '''Histone methyltransferase''' (HMT) are '''histone-lysine N-methyltransferase''' (KHMT) and '''histone-arginine N-methyltransferase''' (RHMT) which catalyzes the transfer of methyl groups to lysine and arginine residues of histones<ref>PMID:15248813</ref>. HMT use S-adenosyl methionine (SAM) or S-adenosyl homocysteine (SAH) as the methyl donor. KHMT can be SET domain-containing or non-SET domain-containing. The SET domain contains the catalytic core of KHMT and targets the lysine tail region of KHMT. CxxC domain is a zinc finger domain. | ||
| + | == Relevance == | ||
| + | Inhibitors of the histone-lysine N-methyltransferase SMYD2 which represses the tumor-suppressing activities of p53 are studied as cancer therapy drugs. | ||
| + | |||
| + | == Disease == | ||
| + | Aberrant HMT plays a role in cancer, intellectual disability syndromes and regulation of tissue aging<ref>PMID:22473383</ref>. | ||
== 3D Structures of histone methyltransferase == | == 3D Structures of histone methyltransferase == | ||
| Line 66: | Line 72: | ||
**[[3sr4]], [[3uwp]], [[4ek9]], [[4ekg]], [[4eki]], [[4eqz]], [[4er0]], [[4er3]], [[4er5]], [[4er6]], [[4er7]], [[4hra]] - hKHMT catalytic domain + inhibitor<br /> | **[[3sr4]], [[3uwp]], [[4ek9]], [[4ekg]], [[4eki]], [[4eqz]], [[4er0]], [[4er3]], [[4er5]], [[4er6]], [[4er7]], [[4hra]] - hKHMT catalytic domain + inhibitor<br /> | ||
**[[2w5y]] – hKHMT Hrx methyltransferase domain + SAH <br /> | **[[2w5y]] – hKHMT Hrx methyltransferase domain + SAH <br /> | ||
| - | **[[3lqi]], [[3lqj]] - hKHMT Mll Phd bromodomain + H3 peptide<br /> | ||
**[[3f2k]] – hKHMT Setmar SET domain + LYFA peptide<br /> | **[[3f2k]] – hKHMT Setmar SET domain + LYFA peptide<br /> | ||
**[[3sw9]], [[3swc]] – hKHMT SET domain + peptide<br /> | **[[3sw9]], [[3swc]] – hKHMT SET domain + peptide<br /> | ||
Revision as of 09:29, 24 March 2016
| |||||||||||
